Long-term high-salt diet causes hypertension and decreases renal expression of vascular endothelial growth factor in Sprague-Dawley rats

Journal of the American Society of Hypertension

Volumn 2, Issue 4, 2008, Pages 275-285

  Gu, Jian Wei ^a   Bailey, Amelia P ^a   Tan, Wei ^a   Shparago, Megan ^a   Young, Emily ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; mean arterial pressure; renal injury; sFlt 1

Indexed keywords

ALBUMIN; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH SODIUM INTAKE; HISTOPATHOLOGY; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY INJURY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; SALT INTAKE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 47049108545     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.03.001     Document Type: Article

References (51)

1. Aviv A. Salt and hypertension: the debate that begs the bigger question. Arch Intern Med 161 (2001) 507-510
2. Frolich E.D., and Varagic J. Sodium directly impairs target organ function in hypertension. Curr Opin Cardiol 20 (2005) 424-429
3. Gu J.W., Anand V., Shek E.W., Moore M.C., Brady A.L., Kelly W.C., et al. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 31 (1998) 1083-1087
4. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. SASH-Sodium Collaborative Research Group. N Engl J Med 344 (2001) 3-10
5. Meneton P., Jeunemaitre X., de Wardener H.E., and Macgregor G.A. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85 (2005) 679-715
6. Guyton A.C. Blood pressure control-special role of the kidneys and body fluids. Science 252 (1991) 1813-1816
7. Hall J.E., Guyton A.C., Smith Jr. M.J., and Coleman T.G. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol Renal Fluid Electrolyte Physiol 239 (1980) F271-F280
8. Masson G.M.C., Aoki K., and Page I.H. Effects of sinoaortic denervation on renal and adrenal hypertension. Am J Physiol 211 (1966) 94-104
9. Dzielak D.J., and Norman Jr. R.A. Renal nerves are not necessary for onset or maintenance of DOCA-salt hypertension in rats. Am J Physiol Heart Circ Physiol 249 (1985) H945-H949
10. Weinberger M.H. Salt sensitivity of blood pressure in humans. Hypertension 27 (1996) 481-490
11. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and potassium excretion. BMJ 297 (1988) 319-328
12. Poulter N., Khaw K.T., Hopwood B.E.C., Mugambi M., Peart W.S., Rose G., et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ 300 (1990) 967-972
13. Forte J.G., Miguel J.M., Miguel M.J., de Padua F., and Rose G. Salt and blood pressure: a community trial. J Hum Hypertens 3 (1989) 179-184
14. Lifton R.P. Molecular genetics of human blood pressure variations. Science 272 (1996) 676-680
15. Corbett W.T., Kuller L.H., Blaine E.H., and Damico F.J. Utilization of swine to study the risk factor of an elevated salt diet on blood pressure. Am J Clin Nutr 32 (1979) 2068-2075
16. Cherchovich G.M., Capek K., Jefremova Z., Pohlova I., and Jelinek J. High salt intake and blood pressure in lower primates (Papio hamadryas). J Appl Physiol 40 (1976) 601-604
17. Srinivasan S.R., Dalferes E.R., Wolf R.H., Radhakrishnamurthy B., Foster T.A., and Berenson G.S. Variability in blood pressure response to dietary sodium intake among African green monkeys (Cercopithecus aethiops). Am J Clin Nutr 39 (1984) 792-796
18. Denton D., Weisinger R., Mundy N.I., Wickings E.J., Dixson A., Moisson P., et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1 (1995) 1009-1016
19. Manning Jr. R.D., Tian N., and Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25 (2005) 311-317
20. Gu J.W., Tian N., Shparago M., Tan W., Bailey A.P., and Manning Jr. R.D. Renal NF-κB activation and TNF-α upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1817-R1824
21. Brooks V.L., Freeman K.L., and Qi Y. Time course of synergistic interaction between DOCA and salt on blood pressure: roles of vasopressin and hepatic osmoreceptors. Am J Physiol Regul Integr Comp Physiol 91 (2006) R1825-R1834
22. Lifton R.P., Gharavi A.G., and Geller D.S. Molecular mechanisms of human hypertension. Cell 104 (2001) 545-556
23. Rodriguez-Iturbe B., Vaziri N.D., Herrera-Acosta J., and Johnson R.J. Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286 (2004) F606-F616
24. Vaziri N.D., and Rodriguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nature Clin Prac Nephrol 2 (2006) 582-593
25. Sandler A.B., Johnson D.H., and Hertst R.S. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer. Clin Cancer Res 10 (2004) 4258S-4262S
26. Holden S.N., Eckhardt S.G., Basser R., de Boer R., Rischin D., Green M., et al. Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and VEGF receptor signaling, in patients with solid, malignant tumors. Ann Oncol 16 (2005) 1391-1397
27. Zangari M., Anaissie E., Stopeck A., Morimoto A., Tan N., Lancet J., et al. Phase II study of SU5416, a small molecular vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma. Clin Cancer Res 10 (2004) 88-95
28. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med 350 (2004) 72-83
29. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal disease. J Clin Invest 111 (2003) 707-716
30. Kang D.H., Kim Y.G., Andoh T.F., Gordon K.L., Suga S.I., Mazzali M., et al. Post-cyclosporin-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol 280 (2001) F727-F736
31. Yau H.T., Li X.Z., Pitera J.E., Long D.A., and Woolf A.S. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia inducible factor-1α. Am J Pathol 163 (2003) 2289-2301
32. Pillebout E., Burtin M., Yuan H.T., Briand P., Woolf A.S., Friedlander G., and Terzi F. Proliferation remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesion. Am J Pathol 159 (2001) 547-560
33. Gu J.W., Llnas M.T., Wang J., Stockton A., and Adair T.H. Low dietary salt intake induces mRNA expression of vascular endothelial growth factor in kidneys of WKY rats. Am J Hypertension 15 (2002) 128A-129A
34. Gu J.W., Elam J., Sartin A., Li W., Roach R., and Adair T.H. Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulation angiogenesis. Am J Physiol Regulatory Integrative Comp Physiol 281 (2001) R368-R721
35. Siegel A.K., Kossmehl P., Planer M., Schulz A., Wehland M., Stoll M., et al. Genetic linkage of albuminuria and renal injury in Dahl salt-sensitive rats on a high-salt diet: comparison with spontaneously hypertensive rats. Physiol Genomics 18 (2004) 218-225
36. Farjah M., Washington T.L., Roxas B.P., Geenen D.L., and Danziger R.S. Dietary NaCl regulates renal aminopeptidase N: relevance to hypertension in the Dahl rat. Hypertension 43 (2004) 282-285
37. Mattson D.L., and Higgins D.J. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 27 (1996) 688-692
38. + balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats. Hypertension 47 (2006) 1101-1107
39. Dahl L.K., Heine M., and Tassinari L. Effects of chronic excess salt ingestion. Role of genetic factors in both doca-salt and renal hypertension. J Exp Med 118 (1963) 605-617
40. DiBona G.F., and Sawin L.L. Exaggerated natriuresis in experimental hypertension. Proc Soc Exp Biol Med 182 (1986) 43-51
41. Praga M., and Morales E. Renal damage associated with proteinuria. Kidney Int 62 (2002) S42-S46
42. Roy H., Bhardwaj S., and Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 580 (2006) 2879-2887
43. Pupilli C., Lasagni L., Romagnani P., Bellini F., Mannelli M., Misciglia N., et al. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. Am J Soc Nephrol 10 (1999) 245-255
44. Shihab F.S., Bennett W.M., Isaac J., Yi H., and Andoh T.F. Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity. Kidney Int 62 (2002) 422-433
45. 2 receptors. Am J Soc Nephrol 14 (2003) 3061-3071
46. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56 (1999) 794-814
47. Schrijvers B.F., Flyvbjerg A., and DeVriese A.S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65 (2004) 2003-2017
48. Villegas G., Lange-Sperandio B., and Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 67 (2005) 449-457
49. Hara A., Wada T., Furuichi K., Sakai N., Kawachi H., Shimizu F., et al. Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int 69 (2006) 1986-1995
50. Sugimoto H., Hamano Y., Charyta D., Cosgrove D., Kieran M., Sudhakar A., et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278 (2003) 12605-12608
51. Hornig C., Barleon B., Ahmad S., et al. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 80 (2000) 443-454